Journal article
EGFR mutation positive non-small cell lung cancer: can we identify predictors of benefit from immune checkpoint inhibitors.
Authors
Wang Y; Ellis P
Journal
Annals of Translational Medicine, Vol. 5, No. 21,
Publisher
AME Publishing Company
Publication Date
November 2017
DOI
10.21037/atm.2017.08.14
ISSN
2305-5839